Skip to main content

ORIGINAL RESEARCH article

Front. Neurosci.
Sec. Neurodevelopment
Volume 18 - 2024 | doi: 10.3389/fnins.2024.1456433

Four heterozygous de novo variants in ASXL3 identified with Bainbridge-Ropers syndrome and further dissecting published genotype-phenotype spectrum

Provisionally accepted
Weitong Guo Weitong Guo 1*Shengjie Ling Shengjie Ling 2*Yiming Zhang Yiming Zhang 2*Ning Li Ning Li 1*Shan Tian Shan Tian 2*Rui Hu Rui Hu 2*Dongdong Zhang Dongdong Zhang 1*
  • 1 Children's Hospital Affiliated to Shandong University, Ji nan, China
  • 2 Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China

The final, formatted version of the article will be published soon.

    Bainbridge-Ropers syndrome (BRPS) is a recently described neurodevelopmental genetic disorder associated with de novo truncating variants in additional sex combs like 3 (ASXL3) on chromosome 18q12.1. Trio-based exome sequencing was conducted on patients admitted to the Children's Hospital Affiliated to Shandong University and diagnosed with unexplained intellectual disabilities or developmental delay between June 2022 and January 2024. De novo truncation of ASXL3 was identified in four patients, and the pathogenic variants and their de novo status were validated using Sanger sequencing. Comprehensive clinical phenotype-genotype information of all previously reported patients with BRPS was collected and summarized. The common clinical manifestations observed in the four patients included language and intellectual disabilities or psychomotor retardation. Genetic analysis revealed that patient 1 carried a de novo heterozygous variant, c.1667_1668del (p.Thr556Arpfs*3), whereas patient 2 had a novel heterozygous frameshift variant of ASXL3, c.3324del(p.Lys1109Serfs*34). These two variants have not been documented to date. Additionally, patients 3 and 4 exhibited a de novo variant, c.4678C>T(p.Arg1560Ter). Based on the combined assessment of clinical phenotypes and genetic testing results, it was postulated that all four children presented with BRPS syndrome caused by pathogenic variations in ASXL3. The present study complements the range of ASXL3 mutational and phenotypic spectra in the population, highlighting subtle distinctions in clinical manifestations between Chinese patients and other racial groups. The reporting of additional cases will contribute to further elucidating the function of ASXL3 and establishing a solid foundation for clinical diagnosis and treatment.

    Keywords: Bainbridge-Ropers syndrome, ASXL3, Intellectual Disabilities, Nonsense variant, whole exome sequencing

    Received: 28 Jun 2024; Accepted: 25 Oct 2024.

    Copyright: © 2024 Guo, Ling, Zhang, Li, Tian, Hu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Weitong Guo, Children's Hospital Affiliated to Shandong University, Ji nan, China
    Shengjie Ling, Central Hospital Affiliated to Shandong First Medical University, Jinan, 271000, Shandong Province, China
    Yiming Zhang, Central Hospital Affiliated to Shandong First Medical University, Jinan, 271000, Shandong Province, China
    Ning Li, Children's Hospital Affiliated to Shandong University, Ji nan, China
    Shan Tian, Central Hospital Affiliated to Shandong First Medical University, Jinan, 271000, Shandong Province, China
    Rui Hu, Central Hospital Affiliated to Shandong First Medical University, Jinan, 271000, Shandong Province, China
    Dongdong Zhang, Children's Hospital Affiliated to Shandong University, Ji nan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.